Grassley Probes Two Drugmakers Over 340B Pricing Program
9/27/2013 7:27:29 AM
Written two drugmakers and demanded they explain why they refused to provide required discounts to an Iowa hospital. The Iowa Republican took this move after confirming with the US Health Resources Services Administration that the drugmakers should have offered lower prices. The hospital, which has not been named, contacted Grassley in July after he began probing alleged abuses of the 340B program. Earlier this week, he wrote CSL Behring, which makes an antidote for blood thinner poisoning called Kcentra, and to Pacira Pharmaceuticals, which makes a drug called Exparel that is used in surgical closing
Help employers find you! Check out all the jobs and post your resume.